Supplement bioavailability enhancement composition patent grant
Summary
USPTO granted Patent No. US12589152B2 to The LIV Group Inc. for a composition combining target supplements with rehydration formulations to enhance bioavailability and absorption rates. The patent, invented by Brandin Besore Cohen and Hayden Andrew Fulstone, covers 19 claims and was filed on December 16, 2022.
What changed
USPTO granted Patent No. US12589152B2 to The LIV Group Inc. covering a composition for enhanced absorption of supplements. The composition includes at least one target supplement and a rehydration formulation that enhances bioavailability, allowing faster and greater absorption compared to ingesting the supplement separately. The composition also provides faster hydration. CPC classifications span A61K pharmaceutical preparations, A23L food/dietary supplements, and A61P therapeutic applications including neurological uses.
This is a patent grant notice providing intellectual property protection, not a regulatory action imposing compliance obligations. No deadlines, required actions, or penalties apply. Entities in the pharmaceutical, supplement, and healthcare industries may reference this patent for freedom-to-operate considerations or competitive intelligence.
Source document (simplified)
Composition for enhanced absorption of supplements
Grant US12589152B2 Kind: B2 Mar 31, 2026
Assignee
The LIV Group Inc.
Inventors
Brandin Besore Cohen, Hayden Andrew Fulstone
Abstract
A composition that includes at least one target supplement and at least one rehydration formulation is described. When the at least one target supplement is ingested as part of the composition, the bioavailability of at least one target supplement is enhanced as compared to when it is ingested separate from the composition. The at least one target supplement is absorbed more quickly and in a greater amount when it is ingested as part of the composition than when it is ingested separate from the composition. The composition also hydrates a subject more quickly.
CPC Classifications
A61K 47/02 A61K 9/0014 A61K 9/0021 A61K 9/127 A61K 31/16 A61K 31/4045 A61K 31/405 A61K 36/84 A61K 47/12 A61K 31/198 A61K 36/185 A61K 47/26 A23L 33/105 A23L 33/125 A23L 33/15 A23L 33/16 A23L 33/10 A23L 33/17 A61P 25/00 A23V 2002/00 A23V 2200/31
Filing Date
2022-12-16
Application No.
18067681
Claims
19
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.